4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-23-027226
EVP, Corp Strategy & Develop sold 9,128 shares at an average $173.48 ($1,583,522)
- EVP, Corp Strategy & Develop acquired 9,128 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-11-09 | Option exercise | +9,128 | $144.67 | $1,320,548 | 34,111 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-11-09 | Sale | −2,585 | $172.77 | $446,610 | 31,526 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-11-09 | Sale | −6,543 | $173.76 | $1,136,912 | 24,983 | D |
| Derivatives | |||||||
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2023-11-09 | Option exercise · Stock Options (Right to Buy) | −9,128 | 0 | D | ||
| Open-market sales · 9,128 sh · avg $173.48 · $1,583,522 | |||||||
Loading xslF345X05/form4.xml…